Plasma MN (carbonic anhydrase IX) and outcome in sunitinib-treated metastatic renal cell cancer

被引：0
|
作者：
Lamparella, Nicholas E.
Ali, Suhail M.
Leitzel, Kim
Carney, Walter P.
Lipton, Allan
机构：
[1] Penn State Milton S Hershey Med Ctr, Penn State Hershey Canc Inst, Hershey, PA USA
[2] Lebanon VA Med Ctr, Lebanon, PA USA
[3] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
[4] WILEX Oncogene Sci, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.405
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
405
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma - Editorial comment
    Marshall, Fray F.
    JOURNAL OF UROLOGY, 2008, 180 (04): : 1302 - 1302
  • [22] Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer
    Korkeila, E.
    Talvinen, K.
    Jaakkola, P. M.
    Minn, H.
    Syrjanen, K.
    Sundstrom, J.
    Pyrhonen, S.
    BRITISH JOURNAL OF CANCER, 2009, 100 (06) : 874 - 880
  • [23] Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib
    Fiala, Ondrej
    Ostasov, Pavel
    Rozsypalova, Aneta
    Hora, Milan
    Sorejs, Ondrej
    Sustr, Jan
    Bendova, Barbora
    Travnicek, Ivan
    Filipovsky, Jan
    Finek, Jindrich
    Buchler, Tomas
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4077 - 4086
  • [24] Is There a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
    Keizman, Daniel
    Rouvinov, Keren
    Sella, Avishay
    Gottfried, Maya
    Maimon, Natalie
    Kim, Jenny J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria
    Peer, Avivit
    Carducci, Michael A.
    Mermershtain, Wilmosh
    Leibowitz-amit, Raya
    Weitzen, Rony
    Berger, Raanan
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 281 - 287
  • [25] Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma
    Leppert, JT
    Lam, JS
    Pantuck, AJ
    Figlin, RA
    Belldegrun, AS
    BJU INTERNATIONAL, 2005, 96 (03) : 281 - 285
  • [26] Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma
    Pantuck, Allan J.
    Klatte, Tobias
    Seligson, David
    Atkins, Michael
    Belldegrun, Arie
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (18) : 3105 - 3107
  • [27] Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management
    Courcier, Jean
    de la Taille, Alexandre
    Nourieh, Maya
    Leguerney, Ingrid
    Lassau, Nathalie
    Ingels, Alexandre
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 15
  • [28] Choi response criteria for prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
    van der Veldt, A.
    Meijerink, M. R.
    van den Eertwegh, A. J.
    Haanen, J. B.
    Boven, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Metastatic Renal Cell Cancer Treated With Sunitinib - Toxicity and Efficacy in the Elderly
    Couto, N.
    Sousa, N.
    Begonha, R.
    Oliveira, J.
    Mauricio, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S278 - S278
  • [30] Carbonic Anhydrase IX Expression Is Associated with Improved Outcome of High-dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma
    Dudek, Arkadiusz Z.
    Yee, Ronald T.
    Manivel, Juan C.
    Isaksson, Rachel
    Yee, Heidi O.
    ANTICANCER RESEARCH, 2010, 30 (03) : 987 - 992
12345